Managing Dabigatran vs Med App
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Managing Dabigatran
This medical app assists healthcare professionals in managing patients prescribed dabigatran. It offers guidance on selecting appropriate treatments, handling bleeding incidents, advising on pre-surgical treatment cessation, and interpreting coagulation results.
- Dose recommendation for dabigatran
- Drug information and interactions
- Bleeding management guidance
- Pre-surgery treatment cessation advice
- Coagulation result interpretation
- Referenced clinical guidelines
Read full descriptionHide full description
The dabigatran App is designed for doctors to help them manage patients on the anticoagulant dabigatran. It will be useful to general practitioners, cardiologists, haematologists, neurologists, anaesthetists, emergency specialists and surgeons. In fact most clinicians will at some time have patients on anticoagulants and would find this App helpful. The Dabigatran App will help you • Select the right treatment for your patient. • Provide safe advice if bleeding occurs including information about Idarucizumab • Recommend when to stop treatment before surgery. • Provide recommendations for managing emergency surgery • Interpret coagulation results. -------------------------------------------------------------------------- Features of the Dabigatran App Dose recommendation The Dabigatran App provides the correct dose for each indication with advice about possible dose changes in the presence of renal impairment Drug information Details of the common side-effects, potential drug interactions and basic pharmacology is immediately available. Managing bleeding Bleeding is a potential problem with any anticoagulant and can be complex to manage. The Dabigatran App provides advice about which treatments to use for both minor and major bleeding including when to use idarucizumab (Praxbind) Managing surgery A common question with any anticoagulant is how long should treatment be stopped before surgery? The Dabigatran App calculates a safe interval between stopping treatment and surgery by including renal function and the time since the last dose. It also offers advice for treatment prior to emergency surgery if the surgery cannot be delayed. Interpreting coagulation results Dabigatran prolongs several coagulation tests. The Dabigatran App combines the results of these tests to give an indication of the dabigtran plasma concentration. Referenced information All recommendations are linked to an information page which is appropriately referenced with links to the relevant publications. Website for feedback The Dabigatran App is linked to the Coagulation Conversation website to allow you to ask questions, provide feedback or even start a discussion. We welcome all feedback. ---------------------------------------------------------------- The advice is based on published reviews and guidelines. Extensive efforts have been made to ensure the accuracy of the information however information may change for specific countries at short notice. The user should refer to the manufacturers datasheet for complete prescribing information. Disclaimer This software is to be used as a guide only and healthcare professionals should use clinical judgement and should individualise care for each patient. In no event shall the author or developer be liable to any party for damages resulting from the use of this application.
Med App
This app serves as a modern hospital handbook and orientation platform for healthcare organizations. It provides essential information and resources for staff within various hospital networks across Australia, New Zealand, and the United Kingdom.
- Modern hospital handbook
- Orientation platform
- Healthcare organization resource
- Extensive hospital listings
- Information for medical staff
Read full descriptionHide full description
Med App is the orientation platform of choice for leading Healthcare organisations. Currently in use at the following locations: Australia NSW -- South Eastern Sydney LHD ● Calvary Health Care Kogarah ● Prince of Wales Hospital ● St George Hospital ● Sutherland Hospital ● Sydney & Sydney Eye Hospital ● War Memorial Hospital -- Sydney Children's Hospital Network ● SCH Randwick ● TCH Westmead -- Central Coast LHD ● Gosford Hospital ● Wyong Hospital -- Far Western LHD ● Broken Hill Hospital -- Hunter New England LHD ● John Hunter Hospital ● Belmont Hospital ● The Maitland Hospital ● Manning Rural Referral Hospital ● Tamworth Rural Referral Hospital ● Armidale Rural Referral Hospital ● Calvary Mater Newcastle ● HNE Mental Health -- Murrumbidgee LHD ● Wagga Wagga Hospital -- Northern NSW LHD ● Lismore Hospital ● The Tweed Hospital -- Western NSW LHD ● Orange Health Service ● Bathurst Hospital ● Dubbo Base Hospital -- Illawarra Shoalhaven LHD ● Shellharbour Hospital ● Shoalhaven Hospital ● Wollongong Hospital ● ISLHD Paeds QLD ● Greenslopes Hospital -- Central West Hospital & Health Service ● Alpha ● Barcaldine ● Blackall ● Longreach ● Primary Health Centres ● Winton -- Metro North Hospital & Health Service ● Royal Brisbane & Women's Hospital ● The Prince Charles Hospital ● Caboolture Hospital ● Kilcoy Hospital ● Redcliffe Hospital -- Central Queensland Hospital & Health Service ● Rockhampton Hospital ● Gladstone Hospital -- Darling Downs Hospital & Health Service -- North West Hospital & Health Service VIC ● Northern Health ● Royal Children's Hospital ● Alfred Health SA -- Central Adelaide LHN ● Royal Adelaide Hospital ● Queen Elizabeth Hospital NT - Alice Springs Emergency Department WA - Perth Children’s Hospital - Joondalup Health Campus NZ ● Bay of Plenty ● Capital and Coast DHB ● Wellington Hospital ● Hutt Valley ● MidCentral DHB United Kingdom ● Chelsea Westminster NHS Trust
Screenshots
Verdict
The clearest difference is review sentiment: Med App at 100% against Managing Dabigatran's 67%. Med App also leads on update cadence (every 8 days vs every 6 months). Managing Dabigatran's advantage is iOS requirement (8.0 vs 16.4). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Managing Dabigatran ships an update every 6 months, Med App every 8 days. The most recent releases landed on November 1, 2026 and November 6, 2026 respectively.
| Parameter | Managing Dabigatran | Med App |
|---|---|---|
| Price | Free | Free |
| Rating | — | 5.0 (3 ratings) — better |
| Positive reviews | 66.7% of reviews | 100.0% of reviews — better |
| Number of ratings | — | 3 — better |
| Update frequency | Every 6 months | Every 8 days — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPod | iPhone, iPad |
| Requires iOS | 8.0 — better | 16.4 |
| Further details — not scored | ||
| Size | 3 MB | 66 MB |
| Age rating | 17+ | 17+ |
| Developer | HealthObs Ltd | MedApps Pty Ltd |
Customer experience
Managing Dabigatran
Med App
In-app purchases
Managing Dabigatran
No in-app purchases
Med App
No in-app purchases
Questions
Is Managing Dabigatran free?
Is Med App free?
Do Managing Dabigatran or Med App have ads?
Which is updated more often, Managing Dabigatran or Med App?
Other comparisons















